Treatment of autochthonous acute hepatitis E with short‐term ribavirin: a multicenter retrospective study
- 14 July 2015
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 36 (3) , 328-333
Abstract
Background & Aims: Hepatitis E virus (HEV) genotypes 3 and 4 cause sporadic cases of infection in developed countries. Being elderly and having an underlying liver disease are the main risk factors for death in this population. Chronic infection has been described in immunocompromised patients. Ribavirin is now the antiviral treatment of choice in solid‐organ‐transplant recipients with chronic HEV infection. We hypothesized that early short‐term treatment of acute HEV infection may be useful for patients with risk factors or undergoing chemotherapy.Methods: Between July 2010 and January 2014, 21 patients diagnosed with acute HEV infection were treated with ribavirin, at 600–800 mg/day for up to 3 months. All serum samples were positive for HEV RNA.Results: Nine patients were treated for severe hepatitis. Six patients were aged >70 years. Four patients were receiving an immunosuppressive therapy for an autoimmune disease and two patients were undergoing chemotherapy for a malignancy. Two patients received a fixed‐dose regimen. For all other patients, ribavirin was stopped when HEV became undetectable in the serum. The median duration of ribavirin treatment was 26 days. Two patients developed severe anaemia. Two patients with encephalopathy died. One patient relapsed transiently. All patients were cleared of HEV and regained normalized liver‐enzyme levels. Immunosuppressive treatment and chemotherapy could be resumed.Conclusions: Treatment of acute HEV infection using ribavirin seems safe and effective. Short‐term treatment tailored to viraemia may be the best regimen for this indication.Keywords
This publication has 16 references indexed in Scilit:
- Ribavirin Therapy for Hepatitis E Virus-Induced Acute on Chronic Liver Failure: A Preliminary ReportAntiviral Therapy, 2012
- Genotype 3 Diversity and Quantification of Hepatitis E Virus RNAJournal of Clinical Microbiology, 2012
- Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver InjuryGastroenterology, 2011
- Treatment of severe acute hepatitis E by ribavirinJournal of Clinical Virology, 2011
- Factors Associated With Chronic Hepatitis in Patients With Hepatitis E Virus Infection Who Have Received Solid Organ TransplantsGastroenterology, 2011
- Hepatitis E virus excretion can be prolonged in patients with hematological malignanciesJournal of Clinical Virology, 2010
- Molecular Evidence of Patient‐to‐Patient Transmission of Hepatitis E Virus in a Hematology WardClinical Infectious Diseases, 2009
- Hepatitis E Virus Genotype 3 Diversity, FranceEmerging Infectious Diseases, 2009
- The role of hepatitis E virus testing in drug‐induced liver injuryAlimentary Pharmacology & Therapeutics, 2007
- Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathyJournal of Viral Hepatitis, 2007